| Literature DB >> 35203719 |
Oksana N Khokhlova1, Natalya A Borozdina1, Elena S Sadovnikova1, Irina A Pakhomova1, Pavel A Rudenko1, Yuliya V Korolkova2, Sergey A Kozlov2, Igor A Dyachenko1.
Abstract
CO2 inhalation is currently the most common method of euthanasia for laboratory rats and mice, and it is often used for further terminal blood sampling for clinical biochemical assays. Lately, this method has been criticized due to animal welfare issues associated with some processes that develop after CO2 inhalation. The stress reaction and the value of the clinical laboratory parameters significantly depend on the used anesthetics, method, and the site of blood sampling. Especially in small rodents, an acute terminal state followed by a cascade of metabolic reactions that can affect the studied biochemical profile may develop and cause unnecessary suffering of animals. The aim of this study was to compare the stability of biochemical parameters of outbred Sprague Dawley rats and CD-1 mice serum collected after CO2 inhalation or the intramuscular injection of tiletamine-zolazepam-xylazine (TZX). The serum content of total protein and albumin, cholesterol, triglycerides, aspartate aminotransferase (AST), alanine aminotr ansferase (ALT), alkaline phosphatase (ALP), total bilirubin, and creatinine was decreased by the injection of TZX in comparison with CO2 inhalation. In addition, the levels of calcium, phosphates, chlorides and potassium were lowered by TZX vs. CO2 administration, while the level of sodium increased. Finally, the level of the majority of serum clinical biochemical parameters in rats and mice tend to be overestimated after CO2 inhalation, which may lead to masking the possible effect of anti-inflammatory drugs in animal tests. Injection anesthesia for small rodents with TZX is a more feasible method for terminal blood sampling, which also reduces the suffering of animals.Entities:
Keywords: CD-1 mice; Sprague Dawley rats; animal care and protection; laboratory rodents; serum biochemistry
Year: 2022 PMID: 35203719 PMCID: PMC8962436 DOI: 10.3390/biomedicines10020512
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059
Clinical biochemistry results for serum of CD-1 mice collected in 5 min after CO2 inhalation or tiletamine–zolazepam–xylazine injection.
| Males | Females | |||
|---|---|---|---|---|
| CO2 ( | TZX ( | CO2 ( | TZX ( | |
| Total protein (g/L) | 54.5 ± 0.8 | 42.4 ± 0.8 *** | 56.3 ± 1.1 | 42.3 ± 1.3 *** |
| Albumin (g/L) | 33.5 ± 0.5 | 26.6 ± 0.4 *** | 40.0 ± 1.8 | 31.7 ± 1.9 ** |
| Globulins (g/L) | 21.1 ± 0.4 | 15.8 ± 0.5 *** | 16.2 ± 1.1 | 10.6 ± 0.8 ** |
| Albumin:Globulin Ratio | 1.6 ± 0.1 | 1.7 ± 0.1 * | 2.7 ± 0.5 | 3.3 ± 0.4 |
| Urea (mmol/L) | 9.5 ± 0.4 | 9.1 ± 0.4 | 7.8 ± 0.2 | 9.0 ± 0.5 |
| Creatinine (µmol/L) | 38.7 ± 0.8 | 41.3 ± 1.1 | 48.7 ± 2.5 | 42.1 ± 1.8 * |
| Cholesterol (mmol/L) | 3.29 ± 0.20 | 2.72 ± 0.19 | 2.73 ± 0.25 | 1.93 ± 0.11 * |
| Triglycerides (mmol/L) | 1.50 ± 0.13 | 1.21 ± 0.08 | 2.16 ± 0.43 | 1.18 ± 0.12 |
| Total bilirubin (µmol/L) | 7.55 ± 0.73 | 5.50 ± 0.43 * | 6.94 ± 0.82 | 6.07 ± 0.32 * |
| ALT (U/L) | 58.9 ± 7.2 | 44.3 ± 6.4 * | 44.1 ± 4.5 | 30.6 ± 1.6 * |
| AST (U/L) | 77.6 ± 5.3 | 49.2 ± 3.0 *** | 66.5 ± 2.5 | 53.3 ± 2.0 ** |
| ALP (U/L) | 76.9 ± 9.1 | 70.0 ± 8.8 | 143.6 ± 9.3 | 128.3 ± 11.7 |
| Calcium (mmol/L) | 2.81 ± 0.03 | 2.30 ± 0.02 *** | 3.15 ± 0.09 | 2.44 ± 0.07 *** |
| Inorganic phosphorus (mmol/L) | 3.87 ± 0.08 | 3.04 ± 0.13 *** | 4.14 ± 0.25 | 3.23 ± 0.18 ** |
| Sodium (mmol/L) | 142.3 ± 1.6 | 152.2 ± 0.6 *** | 144.5 ± 0.9 | 150.6 ± 0.6 *** |
| Potassium (mmol/L) | 16.2 ± 0.4 | 5.2 ± 0.1 *** | 13.5 ± 0.3 | 4.4 ± 0.1 *** |
| Chloride (mmol/L) | 112.0 ± 1.3 | 110.4 ± 0.6 * | 112.6 ± 0.6 | 110.2 ± 0.4 ** |
Data are presented as the mean ± SD; (*)—p < 0.05 TZX vs. CO2; (**)- p < 0.01 TZX vs. CO2; (***)—p < 0.001 TZX vs. CO2.
Clinical biochemistry results for serum of Sprague Dawley rats collected in 5 min after CO2 inhalation or tiletamine–zolazepam–xylazine injection.
| Males | Females | |||
|---|---|---|---|---|
| CO2 ( | TZX ( | CO2 ( | TZX ( | |
| Total protein (g/L) | 70.9 ± 5.1 | 59.2 ± 4.6 *** | 67.0 ± 3.7 | 57.6 ± 4.0 *** |
| Albumin (g/L) | 41.0 ± 1.5 | 34.8 ± 2.2 *** | 39.8 ± 1.5 | 35.1 ± 1.9 *** |
| Globulins (g/L) | 29.8 ± 3.6 | 24.3 ± 3.0 ** | 27.1 ± 2.4 | 22.5 ± 2.4 *** |
| Albumin:Globulin Ratio | 1.4 ± 0.1 | 1.4 ± 0.2 | 1.5 ± 0.1 | 1.6 ± 0.1 |
| Urea (mmol/L) | 9.5 ± 1.1 | 9.0 ± 1.5 | 7.9 ± 0.9 | 7.5 ± 1.1 |
| Creatinine (µmol/L) | 72.3 ± 4.5 | 52.2 ± 3.3 *** | 70.0 ± 3.4 | 59.2 ± 4.3 *** |
| Cholesterol (mmol/L) | 2.79 ± 0.45 | 1.98 ± 0.45 ** | 2.78 ± 0.38 | 2.23 ± 0.31 ** |
| Triglycerides (mmol/L) | 1.04 ± 0.26 | 0.62 ± 0.12 *** | 0.94 ± 0.19 | 0.57 ± 0.12 *** |
| Total bilirubin (µmol/L) | 5.23 ± 1.29 | 3.33 ± 0.80 ** | 3.93 ± 1.11 | 3.21 ± 0.82 |
| ALT (U/L) | 68.2 ± 10.1 | 52.1 ± 8.0 ** | 60.1 ± 11.9 | 37.8 ± 7.3 *** |
| AST (U/L) | 83.8 ± 6.7 | 72.4 ± 8.3 * | 83.7 ± 8.5 | 74.7 ± 6.7 ** |
| ALP (U/L) | 160.0 ± 27.0 | 138.1 ± 26.0 | 100.1 ± 26.3 | 72.3 ± 25.3 * |
| Calcium (mmol/L) | 3.28 ± 0.27 | 2.51 ± 0.20 *** | 2.94 ± 0.31 | 2.56 ± 0.15 ** |
| Inorganic phosphorus (mmol/L) | 4.41 ± 0.68 | 2.17 ± 0.33 *** | 3.65 ± 0.92 | 1.75 ± 0.27 *** |
| Sodium (mmol/L) | 141.9 ± 7.2 | 144.1 ± 6.0 | 132.0 ± 3.3 | 138.1 ± 2.3 *** |
| Potassium (mmol/L) | 11.0 ± 1.5 | 4.6 ± 0.3 *** | 12.5 ± 1.8 | 4.2 ± 0.3 *** |
| Chloride (mmol/L) | 119.9 ± 7.8 | 117.2 ± 5.5 | 114.1 ± 2.1 | 112.8 ± 2.0 |
Data are presented as the mean ± SD; (*)—p < 0.05 TZX versus CO2; (**)—p < 0.01 TZX versus CO2; (***)—p < 0.001 TZX versus CO2.
Figure 1Blood glucose levels in males and females of CD-1 mice (A), and Sprague Dawley rats (B), in the awake state and following 5 min after CO2 inhalation or tiletamine–zolazepam–xylazine (TZX) anesthesia. # p < 0.05 TZX versus awake, * p < 0.05 TZX versus CO2.